Published in J Inherit Metab Dis on February 23, 2012
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J Inherit Metab Dis (2014) 1.60
Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management. J Inherit Metab Dis (2013) 1.39
International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A (2014) 1.19
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab (2013) 1.17
Diagnosing mucopolysaccharidosis IVA. J Inherit Metab Dis (2013) 1.14
Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey. Orphanet J Rare Dis (2014) 1.02
Mortality in patients with morquio syndrome a. JIMD Rep (2014) 0.99
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study. Am J Med Genet A (2015) 0.93
Orthopedic management of the extremities in patients with Morquio A syndrome. J Child Orthop (2014) 0.90
Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther (2015) 0.89
Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y. Pediatr Res (2015) 0.89
Therapies of mucopolysaccharidosis IVA (Morquio A syndrome). Expert Opin Orphan Drugs (2013) 0.85
Morquio A syndrome: diagnosis and current and future therapies. Pediatr Endocrinol Rev (2014) 0.85
Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs (2015) 0.83
Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 study. Am J Med Genet A (2016) 0.83
Role of elosulfase alfa in mucopolysaccharidosis IVA. Appl Clin Genet (2016) 0.82
Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA. Orphanet J Rare Dis (2014) 0.81
Overcoming the barriers to diagnosis of Morquio A syndrome. Orphanet J Rare Dis (2014) 0.80
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome. J Inherit Metab Dis (2016) 0.79
MRI morphometric characterisation of the paediatric cervical spine and spinal cord in children with MPS IVA (Morquio-Brailsford syndrome). J Inherit Metab Dis (2013) 0.78
Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issues. Orphanet J Rare Dis (2016) 0.78
Current therapies for Morquio A syndrome and their clinical outcomes. Expert Opin Orphan Drugs (2016) 0.75
Home infusion with Elosulfase alpha (Vimizim(R)) in a UK Paediatric setting. Mol Genet Metab Rep (2017) 0.75
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med (2006) 4.04
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr (2004) 3.86
Oral health, general health and quality of life. Bull World Health Organ (2005) 3.17
International Morquio A Registry: clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis (2007) 2.21
Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet (1997) 1.98
Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A (2003) 1.82
Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment. Curr Pharm Biotechnol (2011) 1.78
Mucopolysaccharidoses and the eye. Surv Ophthalmol (2006) 1.65
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet A (2005) 1.58
The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child (1995) 1.56
Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders--clinical and echocardiographic findings in 64 patients. Eur J Pediatr (1998) 1.54
The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses. Cardiol Young (2009) 1.46
Cardiac manifestations of the mucopolysaccharidoses. Circulation (1975) 1.41
Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis (1996) 1.40
Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol (1988) 1.39
Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36
Children with mucopolysaccharidosis: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg (1993) 1.30
Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat (2005) 1.27
Clinical definition of the Hurler-Hunter phenotypes. A review of 50 patients. Am J Dis Child (1966) 1.19
Mucopolysaccharidosis type IV as a cause of mitral stenosis in an adult. Br Heart J (1981) 1.16
Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr (1995) 1.14
Echocardiographic study of paediatric patients with mucopolysaccharidosis. Cardiol Young (2010) 1.10
Dental disease, caries related microflora and salivary IgA of children with severe congenital cardiac disease: an epidemiological and oral microbial survey. Pediatr Dent (1996) 1.08
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis (2010) 1.06
Ocular changes in mucopolysaccharidosis IV A (Morquio A syndrome) and long-term results of perforating keratoplasty. Ophthalmologica (1999) 1.06
Upper airways abnormalities and tracheal problems in Morquio's disease. Thorax (2003) 1.05
Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A). Graefes Arch Clin Exp Ophthalmol (1990) 1.04
Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration (2009) 1.03
Echocardiographic abnormalities in type IV mucopolysaccharidosis. Arch Dis Child (1990) 1.03
Cardiovascular changes in children with mucopolysaccharide disorders. Acta Paediatr (2002) 1.01
Airway changes in children with mucopolysaccharidoses. Acta Radiol (2002) 1.01
Retinal involvement in Morquio's syndrome (MPS IV). Ann Ophthalmol (1985) 0.99
Perioperative implications of Morquio syndrome in a 31-year-old woman undergoing aortic valve replacement. J Cardiothorac Vasc Anesth (2009) 0.98
Morquio syndrome: electron microscopic findings. Br J Ophthalmol (2005) 0.96
Electroretinography and fundus oculi findings in Hurler's disease and allied mucopolysaccharidoses. Arch Ophthalmol (1965) 0.96
Impaired degradation of keratan sulphate by Morquio A fibroblasts. Biochem J (1982) 0.96
Transoral decompression and posterior stabilisation in Morquio's disease. Arch Dis Child (1991) 0.95
The classics: Chondro-osteo-dystrophy. roentgenographic and clinical features of a child with dislocation of vertebrae, James F. Brailsford, M.D.: Am. J. Surg. 7:404, 1929. Clin Orthop Relat Res (1976) 0.95
Cardiac involvement in mucopolysaccharidoses: effects of allogeneic bone marrow transplantation. Arch Dis Child (1995) 0.93
Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore) (1988) 0.93
The enzymic defects in Morquio and Maroteaux-Lamy syndrome. Adv Exp Med Biol (1976) 0.93
Glaucoma in the Maroteaux-Lamy syndrome. Am J Ophthalmol (1989) 0.93
Tracheomalacia in an adult with respiratory failure and Morquio syndrome. Respir Care (2007) 0.91
Further electroretinographic studies of patients with mucopolysaccharidoses. Birth Defects Orig Artic Ser (1971) 0.91
Airway management in children with mucopolysaccharidoses. Arch Otolaryngol Head Neck Surg (2009) 0.91
Narrow trachea in mucopolysaccharidoses. Pediatr Radiol (1985) 0.90
Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part III: Odontoid dysplasia. Clin Genet (1988) 0.90
Cataracts in Morquio syndrome (mucopolysaccharidosis IV A). Ophthalmic Paediatr Genet (1993) 0.90
Aortic valve replacement in a patient with morquio syndrome. Heart Surg Forum (2008) 0.90
The Morquio syndrome--light and electron microscopic findings from two corneas. Can J Ophthalmol (1974) 0.89
Dental findings in three siblings with Morquio's syndrome. Int J Paediatr Dent (1999) 0.89
Clinical findings in 12 patients with MPS IV A (Morquio's disease). Further evidence for heterogeneity. Part I: Clinical and biochemical findings. Clin Genet (1988) 0.89
Morquio syndrome: clinical findings in 11 patients with MPS IVA and 2 patients with MPS IVB. Hum Genet (1981) 0.87
Morquio's syndrome: severe aortic regurgitation and late pulmonary autograft failure. J Heart Valve Dis (2006) 0.86
A family with two siblings affected by Morquio syndrome (MPS IV). Electrophysiological and psychophysical findings in the visual system. Arch Ophthalmol (1974) 0.86
[Ocular manifestations in patients affected by Morquio syndrome (MPS IV)]. J Fr Ophtalmol (2010) 0.86
The cornea in connective tissue diseases. Ophthalmology (1978) 0.85
Dental findings in mucopolysaccharidosis type IV A (Morquio's disease type A). Oral Surg Oral Med Oral Pathol (1990) 0.85
Otolaryngologic manifestations of the mucopolysaccharidoses. Ann Otol Rhinol Laryngol (1992) 0.85
Pit and fissure sealants: review of literature and application technique. Minerva Stomatol (2011) 0.84
Coronary intimal sclerosis in Morquio's syndrome. Virchows Arch A Pathol Anat Histol (1978) 0.84
Glaucoma in siblings with Morquio syndrome. Br J Ophthalmol (1990) 0.83
Identification of keratan sulfate in liver affected by Morquio syndrome. Clin Chim Acta (1979) 0.83
The Morquio syndrome: neuropathology and biochemistry. Ann Neurol (1978) 0.83
Clinical utility of endurance measures for evaluation of treatment in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). J Pediatr Rehabil Med (2010) 0.83
Multiple iridociliary cysts in patients with mucopolysaccharidoses. Br J Ophthalmol (2002) 0.82
Pulmonary function in Morquio's disease: A study of two siblings. Chest (1975) 0.82
The oral health needs of children, adolescents and young adults affected by a mucopolysaccharide disorder. JIMD Rep (2011) 0.81
Ocular axial length and corneal refraction in children with mucopolysaccharidosis (MPS I-Hurler). Acta Ophthalmol (2010) 0.80
[Phoniatric aspects of children with mucopolysaccharidosis]. Folia Phoniatr (Basel) (1976) 0.80
Upper airway obstruction during head flexion in Morquio's disease. Am J Med (1980) 0.80
Characterization of keratan sulfate isolated from liver affected by Morquio syndrome. Tohoku J Exp Med (1983) 0.79
Early orthodontic treatment and long-term observation in a patient with Morquio syndrome. Angle Orthod (2005) 0.79
Corneal clouding in the genetic mucopolysaccharidoses: a cell culture study. Clin Genet (1973) 0.79
Measurement of absolute lung volumes by imaging techniques. Eur Respir J (1997) 0.78
Dentinoenamel junction area in primary teeth affected by Morquio's syndrome. J Dent Res (1978) 0.78
Hearing patterns in Morquio's syndrome (mucopolysaccharidosis IV). Arch Otolaryngol (1977) 0.77
Porcine N-acetylgalactosamine 6-sulfatase (GALNS) cDNA sequence and expression in developing teeth. Connect Tissue Res (2002) 0.77
Morquio's syndrome. Am J Otol (1987) 0.77
Anesthetic management for foramen magnum decompression in a patient with Morquio syndrome: a case report. J Anesth (2010) 0.76
Chronic diarrhea in mucopolysaccharidosis IIIB. J Pediatr Gastroenterol Nutr (2009) 0.76
Bone marrow transplantation in children. Tokai J Exp Clin Med (1986) 0.76
Morquio's disease and the hearing organ. ORL J Otorhinolaryngol Relat Spec (1977) 0.76
Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA (2006) 7.60
Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr (2004) 3.86
15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol (2005) 3.13
Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics (2009) 2.44
Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol (2003) 2.37
Retracted A BLOC-1 mutation screen reveals that PLDN is mutated in Hermansky-Pudlak Syndrome type 9. Am J Hum Genet (2011) 2.25
World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest (2007) 2.12
Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome (2013) 1.98
Case-control study of lung function in World Trade Center Health Registry area residents and workers. Am J Respir Crit Care Med (2011) 1.81
The effects of the ACTIVE cognitive training trial on clinically relevant declines in health-related quality of life. J Gerontol B Psychol Sci Soc Sci (2006) 1.69
Arrested development: high-resolution imaging of foveal morphology in albinism. Vision Res (2010) 1.62
The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary function. Environ Health Perspect (2005) 1.60
Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet A (2005) 1.58
Strabismus and amblyopia in bilateral Peters anomaly. J AAPOS (2006) 1.54
Hermansky-Pudlak syndrome (HPS5) in a nonagenarian. J AAPOS (2013) 1.52
Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics (2002) 1.49
The prevalence of attention-deficit/hyperactivity disorder among persons with albinism. J Child Neurol (2007) 1.47
Obstructive airways disease with air trapping among firefighters exposed to World Trade Center dust. Chest (2009) 1.43
Cardiac risk factor awareness and management in patients with systemic lupus erythematosus. Arthritis Rheum (2004) 1.41
The unique association of iris heterochromia with Hermansky-Pudlak syndrome. J AAPOS (2013) 1.39
POINT: Should Oscillometry Be Used to Screen for Airway Disease? Yes. Chest (2015) 1.39
Axenfeld-Rieger syndrome: new perspectives. Br J Ophthalmol (2011) 1.35
Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials (2005) 1.31
The natural history of glaucoma and ocular hypertension after pediatric cataract surgery. J AAPOS (2006) 1.27
Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial. Ann Emerg Med (2011) 1.21
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology (2005) 1.21
International guidelines for the management and treatment of Morquio A syndrome. Am J Med Genet A (2014) 1.19
Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. Hum Genet (2003) 1.19
Spectrum of foveal development in albinism detected with optical coherence tomography. J AAPOS (2006) 1.18
Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest (2007) 1.18
Diagnosing mucopolysaccharidosis IVA. J Inherit Metab Dis (2013) 1.14
Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin Cancer Res (2008) 1.13
Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes. J Occup Environ Med (2009) 1.12
Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study. J AAPOS (2013) 1.10
Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med (2002) 1.06
Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis (2011) 1.06
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Inherit Metab Dis (2010) 1.06
Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve (2011) 1.05
Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol (2003) 1.05
Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. Chest (2002) 1.01
Lung pathologic findings in a local residential and working community exposed to World Trade Center dust, gas, and fumes. J Occup Environ Med (2011) 0.99
Predictors of refusal during a multi-step recruitment process for a randomized controlled trial of arthritis education. Patient Educ Couns (2008) 0.99
Psychosocial impact of renal donation. Can J Urol (1999) 0.99
Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity. J AAPOS (2007) 0.98
Reading acuity in albinism: evaluation with MNREAD charts. J AAPOS (2011) 0.97
A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses. Health Educ Behav (2007) 0.97
Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity. Arch Ophthalmol (2006) 0.97
Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance. Nat Med (2013) 0.96
Chronic hemodialysis in infants and children under 2 years of age. Pediatr Nephrol (2003) 0.96
MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2). Am J Hum Genet (2003) 0.95
Magnetic resonance imaging-based spirometry for regional assessment of pulmonary function. Magn Reson Med (2005) 0.95
Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure. Pediatr Nephrol (2003) 0.94
Vascular access: choice and complications in European paediatric haemodialysis units. Pediatr Nephrol (2011) 0.94
Change in visual acuity in albinism in the early school years. J Pediatr Ophthalmol Strabismus (2011) 0.93
Distal airway function assessed by oscillometry at varying respiratory rate: comparison with dynamic compliance. COPD (2009) 0.92
Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity. Arch Ophthalmol (2004) 0.91
Chronic and acute exposures to the world trade center disaster and lower respiratory symptoms: area residents and workers. Am J Public Health (2012) 0.91
Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2002) 0.90
Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study. Pediatrics (2004) 0.90
Elevated peripheral eosinophils are associated with new-onset and persistent wheeze and airflow obstruction in world trade center-exposed individuals. J Asthma (2012) 0.89
Efficacy of spectacles in persons with albinism. J AAPOS (2004) 0.89
Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol (1985) (2005) 0.88
Evolution of pattern of breathing during a spontaneous breathing trial predicts successful extubation. Intensive Care Med (2009) 0.87
Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesity. Obesity (Silver Spring) (2006) 0.87
The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism. Am J Med Genet A (2009) 0.86
Membrane diffusion in diseases of the pulmonary vasculature. Respir Med (2006) 0.86
Neurodevelopment in children with albinism. Ophthalmology (2008) 0.86
Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Br J Ophthalmol (2010) 0.85
The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia. Exp Hematol (2007) 0.85
Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes. Diabetes Care (2009) 0.84
Outcome of angle surgery in children with aphakic glaucoma. J AAPOS (2010) 0.84
Correlation of recognition visual acuity with posterior retinal structure in advanced retinopathy of prematurity. Arch Ophthalmol (2012) 0.84
Gender-related dimorphism in aortic insufficiency in murine mucopolysaccharidosis type I. J Heart Valve Dis (2009) 0.83
Ophthalmic manifestations of Wolf-Hirschhorn syndrome. J AAPOS (2004) 0.83
Correlation of grating acuity with letter recognition acuity in children with albinism. J AAPOS (2006) 0.83
Facilitating the transition from physiology to hospital wards through an interdisciplinary case study of septic shock. BMC Med Educ (2014) 0.83
Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project. Arthritis Rheum (2007) 0.82
Longitudinal spirometry among patients in a treatment program for community members with World Trade Center-related illness. J Occup Environ Med (2012) 0.82
Distribution of enamel crystallite orientation through an entire tooth crown studied using synchrotron X-ray diffraction. Eur J Oral Sci (2011) 0.82
Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI. J Inherit Metab Dis (2013) 0.82
Positive angle kappa in albinism. J AAPOS (2004) 0.81
Bone-anchored hearing aids versus conventional hearing aids. Adv Otorhinolaryngol (2011) 0.81
Grating acuity in albinism in the first three years of life. J AAPOS (2002) 0.81
Clinical Insights Into Foveal Morphology in Albinism. J Pediatr Ophthalmol Strabismus (2015) 0.80
In search of the silver lining: the impact of Superstorm Sandy on Bellevue Hospital. Ann Am Thorac Soc (2013) 0.80
Treatment Failure Among Infected Periprosthetic Patients at a Highly Specialized Revision TKA Referral Practice. Open Orthop J (2013) 0.80
Assessing efficacy of high-frequency chest wall oscillation in patients with familial dysautonomia. Chest (2005) 0.80
Labor pains: unraveling the complexity of OB decision making. Crit Care Nurs Q (2006) 0.80
β-Blocking and racial variation in the severity of retinopathy of prematurity. Arch Ophthalmol (2012) 0.79
Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis. Acta Ophthalmol (2011) 0.79
Distal airway dysfunction in obese subjects corrects after bariatric surgery. Surg Obes Relat Dis (2011) 0.79
Living donor nephrectomy: follow-up renal function, blood pressure, and urine protein excretion. Can J Urol (1999) 0.79
Data-set visibility: Cite links to data in reference lists. Nature (2012) 0.79
A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction. Am J Ophthalmol (2013) 0.79
Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods. Mutagenesis (2005) 0.79
Glaucoma following cataract surgery in children: surgically modifiable risk factors. Trans Am Ophthalmol Soc (2005) 0.79
Mapping the spatial and temporal progression of human dental enamel biomineralization using synchrotron X-ray diffraction. Arch Oral Biol (2013) 0.79
Positive angle kappa: a possible sign of aniridia. Am Orthopt J (2012) 0.78